PRILUKAE

Serial Number 98855616
686

Registration Progress

Application Filed
Nov 15, 2024
Under Examination
Approved for Publication
May 27, 2025
Published for Opposition
May 27, 2025
Registered

Basic Information

Serial Number
98855616
Filing Date
November 15, 2024
Published for Opposition
May 27, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
May 27, 2025
Application
Pending
Classes
005

Rights Holder

Novita Pharmaceuticals, Inc.

03
Address
445 Park Avenue, Suite 19A
New York, NY 10022

Ownership History

Novita Pharmaceuticals, Inc.

Original Applicant
03
New York, NY

Novita Pharmaceuticals, Inc.

Owner at Publication
03
New York, NY

Legal Representation

Attorney
Norm J. Rich
USPTO Deadlines 1 active 1 overdue
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
OPPOSITION
Notice of Publication
NPUBE Jun 26, 2025 11 days overdue Medium Until Jul 26, 2025

Application History

7 events
Date Code Type Description
May 27, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 27, 2025 PUBO A PUBLISHED FOR OPPOSITION
May 21, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 24, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 23, 2025 DOCK D ASSIGNED TO EXAMINER
Nov 15, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 15, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer.

Classification

International Classes
005